Carl Zeiss licences digital pathology from Olympus

Share this on social media:

Carl Zeiss Microscopy and Olympus America have signed a non-exclusive worldwide licensing agreement allowing Carl Zeiss to access an extensive portfolio of patents held by Olympus in the field of digital pathology and virtual microscopy. The patents included in the licensing deal cover methods and equipment for creating, storing and delivering virtual microscopy slides. The technology enables individuals to view and share high-resolution virtual microscopy images over the Internet.

‘The handling of digital data has become a major driver of the development of modern microscopy,’ said Dr Bernhard Ohnesorge, member of the board and general manager BioSciences Division of Carl Zeiss Microscopy. ‘Integrating the virtual slide functionality into our research microscope systems will enable our customers to become more efficient and to explore new scientific approaches. This will help them to better understand the root causes of the most challenging diseases.’

‘Global adoption of digital slide scanning continues to expand into new medical and scientific applications,’ said Brad Burklow, executive director business development, Scientific Equipment Group, Olympus Corporation of the Americas. ‘Olympus is the holder of many important patents in this area, and we feel it is vital to allow broad access to these technologies in order to advance the field of pathology and medical research. We are confident that leveraging these technologies will enhance healthcare for patients around the world.’

Recent News

14 June 2021

The VDMA pointed to a number of green technologies – including plans for the sixth largest solar power plant in the world to be built in Turkey – that were driving growth in automation equipment sales

10 June 2021

Enis Ersü founded Isra Vision 36 years ago as a spin-off from the Technical University of Darmstadt

07 June 2021

Jochem Herrmann has also stepped down from the EMVA board, while Christoph Garbe, CEO at HD Vision Systems, is among those that have been newly elected

20 May 2021

Dr Mats Gökstorp joined Sick in 2003 with the acquisition of Sick IVP. He was responsible for vision products in 2007, later looking after products and marketing